Cheryl Lassen, a former clinical development executive at Novartis, has been appointed vice president for clinical development at Cytos Biotechnology Ltd in Switzerland, which is developing an immunotherapy for allergic asthma. A medical doctor by training, Dr Lassen’s area of expertise is respiratory diseases. During her 20 years in life science, she has worked on a multitude of clinical development programmes in the UK and South Africa. Separately, Cytos appointed Matthias Alder as executive vice president for corporate development and legal affairs. Mr Alder was most recently general counsel at Micromet Inc, which was acquired by Amgen Inc in 2012.
Cytos announced the appointments on 12 March 2013.
Copyright 2013 Evernow Publishing Ltd.